Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension (VDATH)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011 by Wayne State University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
John M. Flack, Wayne State University
ClinicalTrials.gov Identifier:
NCT01472796
First received: November 11, 2011
Last updated: NA
Last verified: November 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2014
  Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)